Clinical Trial

Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI

Study acronym: DIFOCCULT-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infarct size, better preserve left ventricular function and result in lower long-term adverse cardiac events (all cause mortality, all cause rehospitalization) compared to standard ST-elevation/non-ST-elevation MI paradigm.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-08-23; most recent amendment 2025-09-02.
Status change: Recruiting → Active, Not Recruiting 2025-09-02
Status change: Not Yet Recruiting → Recruiting 2024-11-27
Trial Details
NCT Number NCT06570759
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Collaborators: Ankara Etlik City Hospital, Antalya City Hospital, Bağcılar Training and Research Hospital, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Ataturk University, Eskisehir City Hospital, Kartal Kosuyolu High Speciality Training and Research Hospital, Marmara University Pendik Training and Research Hospital, Istanbul Mehmet Akif Ersoy Educational and Training Hospital, Muğla Sıtkı Koçman University, Necmettin Erbakan University, Eskisehir Osmangazi University, Sirnak State Hospital, Tokat Gaziosmanpasa University, Van Training and Research Hospital, Yuzuncu Yil University, Kutahya Health Sciences University
Conditions Myocardial Infarction, Myocardial Ischemia, Acute Coronary Syndrome, Diagnosis, Morality
Enrollment 6,000 participants
Start Date 2024-10-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-03